AIDS
Brad DeLong
delong at econ.Berkeley.EDU
Wed Jan 24 08:06:54 PST 2001
>[lower-priced] generic versions of HIV/AIDS medications from other
>> countries."
>
>So the question is: What's the qualitative difference between the
>low-cost drugs and the expensive ones?
No chemical difference. They have a lower price. They have a lower
price because pharmaceutical companies are good at using national
borders to segment markets, and good at doing price discrimination.
>Isn't this qualitative difference the least bit suspicious?
No.
More information about the lbo-talk
mailing list